Cargando…
Treatment of Generalized Anxiety Disorder with Gabapentin
Gabapentin is frequently used in the treatment of anxiety disorders. However, there are no randomized controlled trials on the effectiveness of this medication in generalized anxiety disorder (GAD), and there are only a few case reports. We present a case of a 59-year-old female with a psychiatric h...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745655/ https://www.ncbi.nlm.nih.gov/pubmed/29387502 http://dx.doi.org/10.1155/2017/6045017 |
_version_ | 1783288945475321856 |
---|---|
author | Markota, Matej Morgan, Robert J. |
author_facet | Markota, Matej Morgan, Robert J. |
author_sort | Markota, Matej |
collection | PubMed |
description | Gabapentin is frequently used in the treatment of anxiety disorders. However, there are no randomized controlled trials on the effectiveness of this medication in generalized anxiety disorder (GAD), and there are only a few case reports. We present a case of a 59-year-old female with a psychiatric history of GAD. The patient discontinued benzodiazepines after more than 7 years of daily treatment which led to rebound anxiety, benzodiazepine withdrawal symptoms, and suicidal ideation. She was psychiatrically hospitalized and started on gabapentin. Over the next 10 months of outpatient follow-up, she attempted to taper off gabapentin due to personal preference to limit medications. During this time, we observed a clear dose-response pattern of gabapentin on GAD symptoms. In the absence of controlled studies, these findings may offer important information about the effectiveness of gabapentin in GAD. |
format | Online Article Text |
id | pubmed-5745655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-57456552018-01-31 Treatment of Generalized Anxiety Disorder with Gabapentin Markota, Matej Morgan, Robert J. Case Rep Psychiatry Case Report Gabapentin is frequently used in the treatment of anxiety disorders. However, there are no randomized controlled trials on the effectiveness of this medication in generalized anxiety disorder (GAD), and there are only a few case reports. We present a case of a 59-year-old female with a psychiatric history of GAD. The patient discontinued benzodiazepines after more than 7 years of daily treatment which led to rebound anxiety, benzodiazepine withdrawal symptoms, and suicidal ideation. She was psychiatrically hospitalized and started on gabapentin. Over the next 10 months of outpatient follow-up, she attempted to taper off gabapentin due to personal preference to limit medications. During this time, we observed a clear dose-response pattern of gabapentin on GAD symptoms. In the absence of controlled studies, these findings may offer important information about the effectiveness of gabapentin in GAD. Hindawi 2017 2017-12-14 /pmc/articles/PMC5745655/ /pubmed/29387502 http://dx.doi.org/10.1155/2017/6045017 Text en Copyright © 2017 Matej Markota and Robert J. Morgan. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Markota, Matej Morgan, Robert J. Treatment of Generalized Anxiety Disorder with Gabapentin |
title | Treatment of Generalized Anxiety Disorder with Gabapentin |
title_full | Treatment of Generalized Anxiety Disorder with Gabapentin |
title_fullStr | Treatment of Generalized Anxiety Disorder with Gabapentin |
title_full_unstemmed | Treatment of Generalized Anxiety Disorder with Gabapentin |
title_short | Treatment of Generalized Anxiety Disorder with Gabapentin |
title_sort | treatment of generalized anxiety disorder with gabapentin |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745655/ https://www.ncbi.nlm.nih.gov/pubmed/29387502 http://dx.doi.org/10.1155/2017/6045017 |
work_keys_str_mv | AT markotamatej treatmentofgeneralizedanxietydisorderwithgabapentin AT morganrobertj treatmentofgeneralizedanxietydisorderwithgabapentin |